about
A simplified protocol for high-yield expression and purification of bacterial topoisomerase I.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile InfectionSmall-Molecule Inhibition of the C. difficile FAS-II Enzyme, FabK, Results in Selective ActivityCrystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutansThe structure of an iron-containing alcohol dehydrogenase from a hyperthermophilic archaeon in two chemical states
P50
Q36000234-5D00C1A0-1316-4364-AB97-0C7F8E0CFA21Q38958278-8DB10340-D120-4FC7-BEC0-3D50E5615859Q48041819-DBEEE8DD-655E-4F61-8B05-08ECFDF56FE4Q90005185-45FB2461-2204-44B4-A399-232510146D33Q92656162-5ADDC1EF-7D0A-4A84-82D7-F0FA34F2B4F9Q92780663-E2C005B8-A5DD-4D0F-A870-60614DE16695Q92873063-85C26683-99C6-4125-91FB-770FCF6BFD32
P50
description
researcher
@en
wetenschapper
@nl
name
Jesse A Jones
@en
Jesse A Jones
@nl
type
label
Jesse A Jones
@en
Jesse A Jones
@nl
prefLabel
Jesse A Jones
@en
Jesse A Jones
@nl
P31
P496
0000-0001-8006-5661